Sterling

Zealand Pharma vs Eli Lilly vs Novo Nordisk and 1 More Revenue Comparison

Compare financial metrics side-by-side using real SEC EDGAR data

Zealand Pharma logo
Zealand Pharma
Eli Lilly logo
Eli Lilly
Novo Nordisk logo
Novo Nordisk
Pfizer logo
Pfizer

Revenue Comparison

Chart: Revenue Comparison. Values in USD billions. In Q3 2026: Zealand Pharma 0.001, Eli Lilly 24.397, Novo Nordisk 12.196, Pfizer 16.583.

Latest Quarter Comparison

Table: Latest Quarter Comparison. 15 rows across Metric, Zealand Pharma, Eli Lilly, Novo Nordisk, Pfizer.
MetricZealand PharmaEli LillyNovo NordiskPfizer
Market Cap$2.20B$1.26T$179.38B$162.27B
Revenue$1.00M$24.40B$12.20B$16.58B
Cost of Revenue$0$3.93B$2.81B$4.03B
Gross Profit$1.00M$20.46B$9.39B$12.55B
Operating Income$-8.00M$8.61B$3.54B$3.67B
Net Income$-8.00M$6.45B$2.58B$3.24B
R&D Expense$88.00M$4.25B$3.06B$3.02B
Earnings Per Share-$0.12$7.22$0.58$0.56
Gross Margin100.0%83.9%77.0%75.7%
Operating Margin-1350.0%35.3%29.1%22.1%
Net Profit Margin-1350.0%26.4%21.1%19.6%
Free Cash Flow$-28.00M$8.22B$4.33B$4.80B
Cumulative Free Cash Flow$25.00M$117.88B$111.72B$361.51B
Operating Cash Flow$-27.00M$11.40B$6.35B$5.38B
Cash & Equivalents$507.00M$4.88B$6.80B$1.82B

Ask Sterling

Register for a premium account to gain access to Sterling AI.

Get Started

Things you can ask Sterling:

Summarize Tesla's latest earnings reportWhy did NVIDIA's margins expand?Compare Apple vs Microsoft's cash flowWhat's driving EV industry growth?
Menu
Favorites